Category: Therapeutic Area
Therapeutic Area market research reports by Prophecy Market Insights
-
AI-Enabled Drug Discovery and Clinical Trials Market Size, Share, By Offering (Software Solutions and Services), Therapeutic Area (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Diseases, Infectious Diseases, and Others), Application (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, and Biomarker Research), End-User (Biopharmaceutical Industry, Contract Research Organizations (CROs), Academic and Research Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035
AI-Enabled Drug Discovery and Clinical Trials Market Size, Share, By Offering (Software Solutions and Services), Therapeutic Area (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Diseases, Infectious Diseases, and Others), Application (Data Aggregation and Analysis, Clinical ... Read More
-
Systemic Antifungals Market Size, Share, By Drug Classes (Azoles, Echinocandins, Polyenes, and Others), Indication (Aspergillosis, Histoplasmosis, Gastrointestinal Candidiasis, Blastomycosis, Fungal Endocarditis, and Others), End-Users (Hospital & Specialty Clinics, Ambulatory Surgical Centers, Research Institute & Clinical Trial Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035
Prophecy Market Insights published a research report on titled “Systemic Antifungals Market Size, Share, Industy Growth, Trends, Forecast Report, 2025-2039” delivers a detailed overview of the Systemic Antifungals Market in terms of segmentation by size, share, by top players, by type, by the end us ... Read More
-
Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Region - Trends, Analysis, and Forecast till 2035
Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory ... Read More
-
Breast Imaging Market Size, Share, By Product (Mammography, Ultrasound, MRI, Thermography, Saige-Q Software, Quantra Software, Mirai Software, and Others), Type (Ionizing Breast Imaging and Nonionizing Breast Imaging), End Users (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Breast Care Centers), and Region - Trends, Analysis, and Forecast till 2035
Breast Imaging Market Size, Share, By Product (Mammography, Ultrasound, MRI, Thermography, Saige-Q Software, Quantra Software, Mirai Software, and Others), Type (Ionizing Breast Imaging and Nonionizing Breast Imaging), End Users (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical C ... Read More
-
Companion Diagnostics Market Size, Share, By Offerings (Products and Services), Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and, Others), Therapeutic Area (Oncology, Immunology, Neurology, Autoimmune, Cardiovascular, Infectious Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035
Companion Diagnostics Market Size, Share, By Offerings (Products and Services), Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and, Others), Therapeutic Area (Oncology, Immunology, Neurology, Autoi ... Read More
-
Radiopharmaceutical Therapies Market Size, Share, By Radioisotope Type (Iodine-131, Gallium-68, Technetium-99m, Zirconium 89, Copper 64, Radium 223, Fluorine 18, Lutetium-177, Rubidium-82, Indium-111, and Others), By Source (Nuclear Reactors, Cyclotrons, and Others), By Application (Oncology, Cardiology, Gastroenterology, Neurology, Nephrology and Others), By End-User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others) and By Region - Trends, Analysis and Forecast till 2034
In 2023, radiopharmaceuticals therapies market was estimated to be worth USD 15.32 Billion. By 2034, the target market is expected to grow to USD 27.3 Billion. Target market is expanding at a CAGR of 6.6% radiopharmaceutical therapies market involves gathering, analyzing, and interpreting informatio ... Read More
Research Assistance
